amprenavir

(redirected from Agenerase)
Also found in: Medical.
Related to Agenerase: Invirase, Aptivus
Translations

amprenavir

n amprenavir m
References in periodicals archive ?
During his career, he has led multinational development teams from discovery to marketing and has a successful product development record, including Lexiva (R) and the approvals for Agenerase (R), Mepron (R) and Malarone (R).
Chimerix Appoints Michael D. Rogers, Ph.D., as Chief Development Officer
2) [dagger] Lexiva (fosamprenavir) should penetrate CSF similarly to Agenerase (amprenavir).
Low-Level HIV in nervous system tied to worse brain function
Vertex said it sold the royalty stream from Lexiva and Agenerase, which it licensed to Glaxo, to strengthen its financial position and invest in other programs, particularly its hepatitis C drug programs.
Vertex Pharmaceuticals Inc
Kaletra, Agenerase, Invirase and Crixivan are registered trademarks of Abbott Laboratories, GlaxoSmithKline, Hoffmann-La Roche Inc.
APTIVUS(R) Sustains Convincing Anti-HIV Effect Through 48 Weeks
Alka-Seltzer, Maalox, Tums, and Rolaids can interfere with the stomach's absorption of Agenerase, Crixivan, Rescriptor, and Reyataz, while Axid, Pepcid, Tagamet, and Zantac should be entirely avoided by those taking Crixivan, Rescriptor, and Reyataz.
Solutions for an upset stomach
Agenerase is used alongside other anti-viral drugs and is already available in America, Ghana, and Israel, where it has notched up sales of pounds 25million in the first half of the year.
SUZY IN THE CITY: MARKET MOVERS
80 as it received approval from the European Commission to market its Agenerase protease inhibitor, used for HIV patients, in all 15 countries in the EU.
Impressive debut as BG charges to top
Vertex's first approved product is Agenerase (amprenavir), an HIV protease inhibitor, which Vertex co-promotes with Glaxo Wellcome.
Vertex Pharmaceuticals receives United States patent covering assay technology to accelerate drug discovery targeting hepatitis C protease
1) Kaletra, Agenerase and Invirase are registered trademarks of Abbott Laboratories, GlaxoSmithKline and Hoffmann-La Roche Inc.
Positive Opinion in Europe for Tipranavir
However, with a new version of Invirase being developed and the recent re-creation of Agenerase as Lexiva, the pill burden may be significantly decreased, making this treatment combination easier to take in the future.
Triple PI therapy for salvage
Protease Inhibitors Nucleotide Reverse Agenerase (generic name: amprenavir) Transcriptase Inhibitor Crixivan (indinavir) Viread (tenofovir, PMPA) Fortovase (saquinavir) Kaletra (lopinavir plus ritonavir) Nucleoside Reverse Norvir (ritonavir) Transcriptase Inhibitors Viracept (nelfinavir) Combivir (AZT plus 3TC) Epivir (lamivudine, also Nonnucleoside Reverse known as 3TC) Transcriptase Inhibitors Hivid (zalcitabine, ddC) Rescriptor (delavirdine) Retrovir (zidovudine, AZT) Sustiva (efavirenz) Trizivir (abacavir plus AZT plus 3TC) Viramune (nevirapine) Videx (didanosine, ddl) Zerit (stavudine, d4T) Ziagen (abacavir)
New HIV drugs in the pipeline: drug companies have dozens of new anti-HIV drugs under study, with many advantages--and a few drawbacks--compared with existing medications. (Health Update)
Lexiva is a new version of the drug Agenerase and is taken in combination with other HIV drugs.
FDA approves HIV drug
Dictionary browser ?
Full browser ?